Alexopoulou A, Karayiannis P, Hadziyannis S J, Aiba N, Thomas H C
Department of Medicine, Imperial College School of Medicine at St. Mary's, London, UK.
J Hepatol. 1997 Apr;26(4):748-53. doi: 10.1016/s0168-8278(97)80238-3.
BACKGROUND/AIMS: Infection with the hepatitis B e antigen (HBeAg) negative variant of hepatitis B virus (HBV) causes chronic liver disease characterised by occasional acute exacerbations. This virus exhibits a high prevalence of mutations in the core region. Our aim was to study the changes in the pre-core/core region of the virus in relation to exacerbations of the disease.
METHODS/RESULTS: We performed direct sequencing on DNA amplified from 7 sequential sera taken over a 5-year period from a hepatitis B surface antigen (HBsAg) and anti-HBe positive Greek patient infected with the HBeAg negative variant. The patient had chronic hepatitis with several acute exacerbation episodes and underwent interferon therapy twice. We found significant variability in the core region at different time points. To determine whether these variants were present in the initial serum sample and subsequently selected under immune pressure or whether they arose de novo during the course of the disease, we cloned the pre-core/core region from 4 sera before and after episodes of acute exacerbation. Fifteen clones from each time point were sequenced. Fourteen nucleotide mutations in the pre-core/core region were recorded, 7 (50%) of which led to amino-acid substitutions. All the amino-acid changes occurred at recognised B- and CD4+ epitopes. The cloning results indicate the presence of quasi-species in all the samples investigated. Some of the variants present as a minor population in the first sample appear to have been selected and become dominant in subsequent sera. However, the emergence of novel variants, not present at a detectable level in earlier samples, during the course of the disease, was also established. The quasi-species nature of HBV only became apparent after the cloning experiments and was not obvious from the direct sequencing results.
New dominant variants occurring during the course of the disease arose either by the selection of pre-existing mutants that were not detected by direct sequencing or by mutation of existing strains. All changes were located within B- and CD4+ epitopes. The continuous production and selection of variants may enable virus to evade elimination by the immune system, resulting in persistent infection.
背景/目的:感染乙型肝炎病毒(HBV)的乙型肝炎e抗原(HBeAg)阴性变异体可导致以偶尔急性发作为特征的慢性肝病。这种病毒在核心区域的突变发生率很高。我们的目的是研究病毒前核心/核心区域的变化与疾病发作的关系。
方法/结果:我们对一名感染HBeAg阴性变异体的希腊患者进行了直接测序,该患者乙肝表面抗原(HBsAg)和抗-HBe呈阳性,在5年期间采集了7份连续血清样本进行DNA扩增。该患者患有慢性肝炎并伴有多次急性发作,接受了两次干扰素治疗。我们发现在不同时间点核心区域存在显著变异性。为了确定这些变异体是在初始血清样本中就存在并在免疫压力下随后被选择,还是在疾病过程中重新出现,我们从急性发作前后的4份血清中克隆了前核心/核心区域。对每个时间点的15个克隆进行测序。在前核心/核心区域记录了14个核苷酸突变,其中7个(50%)导致氨基酸替换。所有氨基酸变化均发生在公认的B细胞和CD4 + 表位上。克隆结果表明在所有研究样本中均存在准种。在第一个样本中作为少数群体出现的一些变异体似乎在随后的血清中被选择并成为优势群体。然而,在疾病过程中也发现了在早期样本中未检测到的新变异体的出现。HBV的准种性质仅在克隆实验后才变得明显,从直接测序结果中并不明显。
在疾病过程中出现的新的优势变异体要么是通过选择直接测序未检测到的预先存在的突变体产生的,要么是现有菌株发生突变产生的。所有变化都位于B细胞和CD4 + 表位内。变异体的持续产生和选择可能使病毒能够逃避免疫系统的清除,从而导致持续感染。